https://www.patlynk.com/fr/trial/NCT00001398
A Phase I/II Trial of Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) in Patients...
This trial, sponsored by Amgen, Inc., which produces the recombinant methionyl human stem cell factor (r-metHuSCF), also involves two other institutions. The pr
stem cell factorphase itrialrecombinantmethionyl